Fast Facts

Posted March 14th, 2011 in by GrossesVeines

The VEIN CONSULT Program aims to improve the care of millions worldwide who suffer from this chronic inflammatory disease.

The VEIN CONSULT Program, an initiative launched by the Union Internationale de Phlébologie (UIP), is the largest global effort to raise awareness of chronic venous disease (CVD) among patients, healthcare professionals and health authorities. The screening program aims to increase knowledge of this common and debilitating disease and to encourage general practitioners to be aware of the need for early detection and management to help prevent disease-related complications.

“Chronic venous disease causes a great deal of suffering for patients and can limit their daily activities”, said Professor Eberhard Rabe, president of the International Union of Phlebology. “But despite the great burden of the disease, there is an international lack of awareness, and significant under-diagnosis and under-treatment. There is an urgent need for patients to get an earlier diagnosis in a primary care environment so that they receive appropriate treatment for their condition, before it progresses.”

The observational, multicenter, descriptive survey was initiated during 2009-2010 in 20 countries: Brazil, Colombia, France, Georgia, Hungaria, Indonesia, Mexico, Pakistan, Romania, Russia, Serbia, Singapore, Slovakia, Slovenia, Spain, Thailand, Ukraine, Unit Arabs Emirates, Vietnam, Venezuela. More than 4,500 selected GPs and 500 selected specialists participated in Step 1 and 2 of the VEIN CONSULT Program, screening around 95,000 patients. The Vein Consult Program is the largest ever epidemiological study performed in the field of Phlebology.



is supported by an unrestricted grant from Servier research group
Terms of use - Cookies policy - Cookies management
Report a side-effect with a drug.

Access to this website is intended for the use of Healthcare Professionals only. By clicking the button "I agree" herebelow, you certify being a Healthcare Professional.